Trends in the Use of Conventional and New Pharmaceuticals for Hemophilia Treatments Among Medicaid Enrollees, 2005-2020.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 34076701.
- Also identified by DOI 10.1001/jamanetworkopen.2021.12044 and PMC identifier 8173373.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cohort study used Medicaid data to examine trends in the use of and spending for hemophilia pharmaceuticals from 2005 to 2020.
Medical subject headings
- Health Services Accessibility
- Hemophilia A
- Managed Care Programs
- Patient Satisfaction